Page 86 - Amgen News Today

First Merchants Corp lessened its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 13,007 shares of the medical research company’s stock after selling 251 shares during the quarter. First Merchants Corp’s holdings […]

Boston Trust Walden Corp lessened its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 43,660 shares of the medical research company’s stock after selling 290 shares during the quarter. Boston […]

Forza Wealth Management LLC lessened its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,884 shares of the medical research company’s stock after selling 120 shares during the quarter. Forza Wealth Management […]

These drugmakers have made important moves over the past year.

Allworth Financial LP lowered its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.7% in the 4th quarter, Holdings Channel reports. The firm owned 16,493 shares of the medical research company’s stock after selling 631 shares during the quarter. Allworth Financial LP’s holdings in Amgen were worth $4,750,000 at the end of the most […]

This preliminary descriptive report compares the rates of detecting high- and low-grade prostate cancer in men invited for prostate cancer screening vs

Royal Bank of Canada restated their outperform rating on shares of Amgen (NASDAQ:AMGN – Free Report) in a report published on Wednesday morning, Benzinga reports. They currently have a $329.00 target price on the medical research company’s stock. A number of other brokerages have also recently commented on AMGN. UBS Group reduced their price target […]

Stratos Wealth Partners LTD. boosted its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,912 shares of the medical research company’s stock after purchasing an […]

Forza Wealth Management LLC decreased its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,884 shares of the medical research company’s stock after selling 120 shares during […]

Sowell Financial Services LLC trimmed its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 6.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,692 shares of the medical research company’s stock after selling 794 shares during the period. […]